CA-INGRAM-MICRO
INGRAM MICRO CLOUD SUMMIT – Ingram Micro Inc. today announced the next iteration of the Ingram Micro Cloud Marketplace, adding new features, functionality and resources designed to help technology partners and independent software vendors (ISVs) to do more with more. Inspired by partner feedback, the new enhancements streamline and standardize processes, increase efficiencies and effectiveness in sales and marketing, and ultimately will make it easier for technology partners and ISVs to grow their business more profitably using the Ingram Micro Cloud Marketplace.
Among the key enhancements and features readily available today as part of the Ingram Micro Cloud Marketplace are:
Ingram Micro Connect – Powered by CloudBlue, Ingram Micro Connect is an easy-to-use, digital module that provides a fast and cost-effective way to publish, manage and promote cloud services to as many as 200,000 technology partners using Ingram Micro Cloud Marketplace. Ingram Micro Connect simplifies and automates distribution by providing robust publishing tools, digital contracting, multi-marketplace targeting, and sales and marketing content creation tools.
New Customer Experience – A new, modern UI for the Ingram Micro Cloud Marketplace featuring an updated, user-friendly interface that makes it easier for technology partners to find, navigate, and purchase cloud services while streamlining end-customer management.
Sales & Marketing Hub – An industry-first, digital suite for technology partners designed to help educate and enable their salespeople on cloud services while providing pre-built campaign templates and valuable marketing tools to their marketers. The complementary resource provides a single destination to discover and learn about cloud services, create and execute marketing campaigns, and customize sales enablement and access industry insights so they can be the go-to cloud experts for their customers.
Marketplace API – A new API that enables technology partners to quickly integrate their own online storefront, CRM and billing systems into the Ingram Micro Cloud Marketplace. As a result, technology partners using the Cloud Marketplace can now better manage and automate ordering and billing; create and manage customer accounts, users and subscriptions; and retrieve billing data that can be used to bill end customers.
“Ingram Micro has elevated the experience our technology partners and ISVs are having with the Ingram Micro Cloud Marketplace, enabling them simply to do more with more and capitalize on the growing opportunity cloud continues to deliver,” said Tarik Faouzi, Vice President of Cloud Product Management, Ingram Micro. “These enhancements, powered by CloudBlue, all tie to Ingram Micro’s overall vision to provide our partners a hyper-scale digital platform, access to an infinite ecosystem, and proven go-to-market services.”
Ingram Micro’s Cloud Marketplace was first to market in 2009, and is now used by more than 55,000 technology partners worldwide to manage nearly four million fully-automated seats. The Ingram Micro Cloud Marketplace can be found here .
Supporting Partner Quotes and Industry Statistics
“Using Ingram Micro Connect, we’re able to quickly add our cloud
products to the Cloud Marketplace and position them in front of Ingram
Micro’s thousands of resellers with uniform, ready-to-use sales and
marketing resources.”
- Dmitry Leonov, Co-Founder, SaneBox
Channel partners spend up to 40 percent of their time sifting through
content.
- Source: Quotient, “Five Step Guide to Enable Channel
Sale,” May 2016
When enabled, resellers achieve 28 percent shorter sales cycles and a 12
percent higher lead conversion rate.
- Source: Aberdeen Group,
“Territory, Training, Technology: Best-in-Class Channel Sales
Management,” March 2016
A recent study from The 2112 Group notes 73% of MSPs don’t have
marketing plans or programs; 52% of partners say they’re expanding sales
and marketing efforts of existing products and services to grow their
business in 2019.
- Source: The 2112 Group, “2017 State of the
U.S. Cloud Channel Report”
“The Sales & Marketing Hub helps significantly reduce the time it takes
us to learn about vendor products and create the sales and marketing
assets that go along with them. Plus, we now have access to a library of
research on cloud business strategies and industry news that will help
us develop more effective strategies for our cloud business. GetBEE
looks forward to growing on the Sales & Marketing Hub with Ingram Micro.”
-
Thea Myhrvold, Founder and CEO, GetBEE
“Together, these new additions to the Cloud Marketplace will enable our
technology vendor partners to automate more processes and, as a result,
not only operate more efficiently to increase profits, but also to
expand their market footprint, and enable our reseller partners to
monetize an ever larger pool of anything as a service.”
- David
Wippich, CTO and Senior Vice President, Global Cloud, Ingram Micro
About Ingram Micro Cloud
At Ingram Micro Cloud,™ we view cloud not just as a single technology, but as a foundational platform to run and drive a whole new way of doing business. By leveraging our platforms and ecosystem, cloud service providers, telecom companies, resellers and enterprises can quickly transform and get up and running in the cloud within minutes, with little to no investment. Our portfolio includes vetted security, communication and collaboration, business applications, cloud management services and infrastructure solutions designed to help clients monetize and manage the entire lifecycle of cloud and digital services, infrastructure and IoT subscriptions. For more information, please visit: www.IngramMicroCloud.com .
About Ingram Micro Inc.
Ingram Micro helps businesses Realize the Promise of Technology ™. It delivers a full spectrum of global technology and supply chain services to businesses around the world. Deep expertise in technology solutions, mobility, cloud, and supply chain solutions enables its business partners to operate efficiently and successfully in the markets they serve. Unrivaled agility, deep market insights and the trust and dependability that come from decades of proven relationships, set Ingram Micro apart and ahead. More at www.ingrammicro.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190313005555/en/
Contact:
Global Media Contact: Marie Rourke WhiteFox Marketing Inc. (for CloudBlue and Ingram Micro) 714-292-2199 marie@whitefoxpr.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom